ArticleOne health outlook2026
Two decades (2005 to 2025) of avian influenza research trends, knowledge gaps and distribution of emerging H5N1 2.3.4.4b clade in South Asia.
Article in One health outlook, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Trends, Gaps, and Challenges in Antiviral Resistance: A Bibliometric Analysis and Narrative Synthesis of Key Viruses, Resistance Mechanisms, and Drivers.BioMed research international · 2026Article
- Global Bibliometric and Phylogenetic Analysis of mcr-Mediated Colistin Resistance.BioMed research international · 2026Article
- First Comprehensive Global Bibliometric Analysis of Monkeypox Virus Research Landscape From 1976 to 2025.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Avian influenza virus (AIV) remains a persistent zoonotic and economic threat in South Asia, yet a comprehensive understanding of its research trajectory, outbreak patterns, and viral evolution in the region remains limited. This study integrates bibliometric, epidemiological, metadata, and phylogenetic analyses to assess two decades (2005–2025) of AIV research and H5N1 dynamics in South Asia. Bibliographic records were retrieved from Scopus and analysed using VOSviewer and Biblioshiny, while hemagglutinin (HA) gene sequences of H5N1 clade 2.3.4.4b were obtained from GISAID and analysed using maximum-likelihood phylogenetic tree. A total of 858 documents were identified, exhibiting a strong upward research trend (R²=0.90), with peak outputs between 2021 and 2024; primary research articles dominated (84.9%), and Bangladesh, India, and Pakistan emerged as the most productive countries and institutional hubs. Keyword evolution revealed sustained focus on avian influenza, H5N1, poultry, and Bangladesh, alongside the post-2020 emergence of One Health, zoonoses, and mutation-related themes. Epidemiological synthesis showed 18 confirmed human H5N1 cases reported between 2005 and 2025, predominantly in Bangladesh, indicating low but recurrent spillover events. Phylogenetic analysis of 267 clade 2.3.4.4b HA sequences revealed multiple well-supported country- and time-specific clades, with Bangladesh acting as a major center of viral persistence and evolution, particularly in domestic ducks, while cross-country clustering among Bangladesh, India, Sri Lanka, and the Maldives suggests regional viral movement likely mediated by migratory birds and poultry trade networks. Collectively, these findings highlight an interconnected H5N1 ecosystem shaped by surveillance intensity, host ecology, and transboundary transmission, underscoring the need for strengthening One Health–oriented surveillance, cross-border collaboration, and sustained genomic monitoring in South Asia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.